This is a Phase 1b/2, single-arm, open-label, dose-escalation study including 2 stages: Phase 1b: Dose-Escalation Stage (Single-Dose and Consecutive-Dose Peri…

Small Cell Lung CancerAdvanced Solid Malignant Tumor

~Estimated

~$10 – $8,750

Chipscreen Biosciences, Ltd.NCT05271292

Observational

High-resolution Specimen PET-CT Imaging for the Intraoperative Visualization of Resection Margins: an Exploratory Study

Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are…

CancerSolid Malignant TumorsSCC - Squamous Cell Carcinoma+2 more

~Estimated

~$10 – $6,250

Vanderbilt-Ingram Cancer CenterNCT06915454

A Prospective Diagnostic Cohort Study to Compare the Accuracy of Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors

The goal of this clinical trial is to better tell apart whether kidney tumors are benign (not cancer) or malignant (cancer) based on a biopsy or imaging tests …

Kidney TumorRenal Benign NeoplasmRenal Malignant Tumor

~Estimated

~$10 – $750

Loyola UniversityNCT05728957

← PreviousPage 2 of 2Next →